OTCMKTS:INLX Intellinetics - INLX Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Intellinetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $4.14 +0.02 (+0.49%) (As of 03/22/2023 12:00 AM ET) Add Compare Share Share Today's Range$4.03▼$4.2350-Day Range$3.90▼$4.6452-Week Range$3.25▼$11.94Volume895 shsAverage Volume4,661 shsMarket Capitalization$16.83 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort Interest About Intellinetics (OTCMKTS:INLX) StockIntellinetics, Inc. engages in the provision of document services and software solutions to private and public sectors. It operates through the following segments: Document Management and Document Conversion. The Document Management segment allows customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video and emails. The Document Conversion provides assistance to clients as a part of overall document strategy to convert documents from one medium to another, predominantly paper to digital, including migration to software solutions, as well as long-term storage and retrieval services. The company was founded by A. Michael Chretien, Matthew L. Chretien, and Thomas D. Moss on October 3, 1997 and is headquartered in Columbus, OH.Read More Receive INLX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Intellinetics and its competitors with MarketBeat's FREE daily newsletter. Email Address INLX Stock News HeadlinesMarch 20, 2023 | finance.yahoo.comIntellinetics to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call on March 27March 3, 2023 | ca.finance.yahoo.comIntellinetics, Inc. (INLX) Interactive Stock Chart - Yahoo FinanceMarch 22, 2023 | Investing Daily (Ad)This Trade Strategy Outpaces Almost AnythingDespite the volatility of the last few years, this reclusive millionaire hasn’t closed a losing trade since July 2016. He just plugs away, executing what may be the most effective investment strategy on Earth. He turned $50K into $5.3M! Want to see the details? Click HERE to watch it for yourself. February 23, 2023 | msn.comBrightcove (BCOV) Reports Q4 Loss, Lags Revenue EstimatesFebruary 16, 2023 | finance.yahoo.comIntellinetics to Participate in Winter Wonderland Best Ideas Virtual Investor ConferenceFebruary 14, 2023 | finance.yahoo.comIntellinetics Completes Digital Conversion of Vital Records for Garden City, MichiganJanuary 26, 2023 | finance.yahoo.comIntellinetics to Ring Closing Bell at The New York Stock ExchangeDecember 20, 2022 | finance.yahoo.comIntellinetics Announces Retirement of Vice President of Products and Services Terry BuchananMarch 22, 2023 | Investing Daily (Ad)This Trade Strategy Outpaces Almost AnythingDespite the volatility of the last few years, this reclusive millionaire hasn’t closed a losing trade since July 2016. He just plugs away, executing what may be the most effective investment strategy on Earth. He turned $50K into $5.3M! Want to see the details? Click HERE to watch it for yourself. December 5, 2022 | finance.yahoo.comIntellinetics Announces New Release of YellowFolderNovember 16, 2022 | finance.yahoo.comIntellinetics Names Experienced Audit and Reporting Expert John Guttilla to Board of DirectorsNovember 15, 2022 | seekingalpha.comIntellinetics, Inc. (INLX) Q3 2022 Earnings Call TranscriptNovember 15, 2022 | finance.yahoo.comIntellinetics Grows Revenue 22%November 1, 2022 | msn.comAirbnb, Inc. (ABNB) Q3 Earnings and Revenues Beat EstimatesNovember 1, 2022 | finance.yahoo.comIntellinetics to Host Third Quarter 2022 Financial Results Conference Call on November 14October 31, 2022 | finance.yahoo.comIntellinetics Launches New Accounts Payable Automation Solution at Constellation Homebuilder Systems’ Build Smarter 2022 ConferenceOctober 25, 2022 | finance.yahoo.comIntellinetics Introduces New Employee Onboarding Automation Solution at Ohio Provider Resource Association Fall ConferenceSeptember 13, 2022 | reuters.comINLX.N - Intellinetics Inc | Stock Price & Latest News | ReutersSeptember 6, 2022 | finance.yahoo.comIntellinetics, Inc. Announces Uplist to NYSE American ExchangeAugust 18, 2022 | finance.yahoo.comIntellinetics Announces the Creation of a New K-12 DivisionAugust 16, 2022 | finance.yahoo.comIntellinetics Announces Rescheduling of Annual MeetingAugust 16, 2022 | finance.yahoo.comIntellinetics, Inc. Reports Second Quarter ResultsAugust 14, 2022 | markets.businessinsider.comIntellinetics is about to announce earnings — here's what Wall Street expectsAugust 9, 2022 | nasdaq.comAngi (ANGI) Reports Q2 Loss, Tops Revenue EstimatesAugust 9, 2022 | finance.yahoo.comIntellinetics Announces Date of Second Quarter 2022 ResultsAugust 4, 2022 | nasdaq.comDHI Group (DHX) Meets Q2 Earnings EstimatesJune 23, 2022 | finance.yahoo.comIntellinetics Announces Adjournment of Annual Meeting of Stockholders Due to Lack of QuorumSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive INLX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Intellinetics and its competitors with MarketBeat's FREE daily newsletter. Email Address INLX Company Calendar Last Earnings11/15/2021Today3/22/2023Next Earnings (Estimated)3/22/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Prepackaged software Sub-IndustryN/A SectorComputer and Technology Current SymbolOTCMKTS:INLX CUSIPN/A CIK1081745 Webwww.intellinetics.com Phone(614) 921-8170FaxN/AEmployees93Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$1.36 million Net Margins-1.18% Pretax Margin-1.18% Return on Equity3.49% Return on Assets1.18% Debt Debt-to-Equity Ratio0.31 Current Ratio0.79 Quick Ratio0.78 Sales & Book Value Annual Sales$11.46 million Price / Sales1.46 Cash Flow$0.67 per share Price / Cash Flow6.17 Book Value$0.94 per share Price / Book4.38Miscellaneous Outstanding Shares4,070,000Free Float3,746,000Market Cap$16.77 million OptionableNot Optionable Beta0.37 Key ExecutivesJames F. DeSocioPresident, Chief Executive Officer & DirectorMike BeckVice President-OperationsJoe SpainChief Financial Officer & TreasurerMatt ChretienSecretary, Director, CTO & Chief Strategy OfficerThomas D. MossVice President-Research & DevelopmentKey CompetitorsFalconStor SoftwareOTCMKTS:FALCUMeWorldOTCMKTS:UMEWFWaveDancerNASDAQ:WAVDIveda SolutionsOTCMKTS:IVDASeaChange InternationalNASDAQ:SEACView All Competitors INLX Stock - Frequently Asked Questions How have INLX shares performed in 2023? Intellinetics' stock was trading at $4.27 at the beginning of the year. Since then, INLX stock has decreased by 3.5% and is now trading at $4.12. View the best growth stocks for 2023 here. When is Intellinetics' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 22nd 2023. View our INLX earnings forecast. How were Intellinetics' earnings last quarter? Intellinetics, Inc. (OTCMKTS:INLX) posted its quarterly earnings data on Monday, November, 15th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of $0.01 by $0.09. The business earned $3.17 million during the quarter, compared to analyst estimates of $2.79 million. Intellinetics had a negative net margin of 1.18% and a positive trailing twelve-month return on equity of 3.49%. What other stocks do shareholders of Intellinetics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Intellinetics investors own include Co-Diagnostics (CODX), Tonix Pharmaceuticals (TNXP), Inovio Pharmaceuticals (INO), Kopin (KOPN), Onconova Therapeutics (ONTX), OPKO Health (OPK), Precipio (PRPO), Selecta Biosciences (SELB), Sierra Oncology (SRRA) and T2 Biosystems (TTOO). What is Intellinetics' stock symbol? Intellinetics trades on the OTCMKTS under the ticker symbol "INLX." How do I buy shares of Intellinetics? Shares of INLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Intellinetics' stock price today? One share of INLX stock can currently be purchased for approximately $4.12. How much money does Intellinetics make? Intellinetics (OTCMKTS:INLX) has a market capitalization of $16.77 million and generates $11.46 million in revenue each year. How can I contact Intellinetics? Intellinetics' mailing address is 2190 DIVIDEND DRIVE, COLUMBUS OH, 43228. The official website for the company is www.intellinetics.com. The company can be reached via phone at (614) 921-8170 or via email at contactus@intellinetics.com. This page (OTCMKTS:INLX) was last updated on 3/22/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.